Data protection Impressum

Financing

The transaction marks a major milestone for the Vaud-based software company, reinforcing its leadership in AI-powered Digital Employee Experience solutions.

Vista Equity Partners acquires majority stake in Nexthink in USD 3 billion deal

29 October 2025

Neuchâtel-based start-up Symactiv has won the 2025 BCN Innovation Prize and CHF 150,000 for its biofertilizer pellets designed to restore soil health and productivity.

Symactiv wins the 2025 BCN Innovation Prize for its sustainable soil regeneration technology

27 October 2025

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Adaptyv raises USD 8 million to accelerate AI-powered protein validation

27 October 2025

Switzerland leads the Global Investment Risk and Resilience Index, reflecting its exceptional stability, innovation capacity, and governance quality.

Switzerland ranked world’s most secure country for investment

27 October 2025

Lausanne-based biotech ADC Therapeutics has secured USD 60 million in new financing to expand commercialization of its cancer treatment ZYNLONTA.

ADC Therapeutics raises USD 60 million to strengthen oncology portfolio

21 October 2025

Bernese cleantech company Solarify has raised more than CHF 24 million through crowdfunding, reaching 20 GWh of solar power generation.

Solarify raises over CHF 24 million as its crowd-financed solar projects surpass 20 GWh

14 October 2025

Agtech pioneer Ecorobotix secures USD 150 million to advance its Plant-by-Plant™ AI technology and unveil new innovation at Agritechnica.

Ecorobotix raises USD 150 million to accelerate AI-powered precision farming

13 October 2025

A CHF 2.1 million endowed professorship will strengthen data-driven cancer medicine at the University of Bern and Inselspital.

New endowed professorship to advance digital cancer medicine in Bern

13 October 2025

HemostOD has raised CHF 4.3 million in a Seed-extension round to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets. The new funding marks a key milestone for the EPFL spin-off as it transitions from proof-of-concept to large-scale manufacturing.

HemostOD raises CHF 4.3 million to scale production of universal blood platelets

6 October 2025

1 2 3 4 5 6 7 8 9 10 … 40